Beaulieu, J. et al. (2008) A beta-arrestin 2 signaling complex mediates lithium action on
behavior. Cell 132:125--136
Stone, E. (1763) An Account of the Success of the Bark of the Willow in the Cure of Agues.
Phil. Trans. Roy. Soc. Lond. 53:195-200
Fleming, A. (1929) On the antibacterial action of cultures of a Penicillium, with special
reference to their use in isolation of B. influenzae. Br. J. Exp. Pathol.
10:226-236
Bickerton, R.K. (1963) The response of isolated strips of cat spleen to sympathomimetic
drugs and their antagonists. J. Pharmacol. Exp. Ther. 142:99-9110
Shapiro, D.A. et al. (2003) Aripiprazole, a novel atypical antipsychotic drug with a
unique and robust pharmacology. Neuropsychopharmacology 28:1400-1411
Berg, K.A. et al. (1998) Effector pathway-dependent relative efficacy at serotonin type 2A
and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol.
Pharmacol. 54:94-9104
Strickland, S. and Loeb, J.N. (1981) Obligatory separation of hormone binding and
biological response curves in systems dependent upon secondary mediators of hormone
action. Proc. Natl. Acad. Sci. U. S. A. 78:1366-1370
Brown, L. et al. (1992) Spare receptors for β-adrenoceptor-mediated positive
inotropic effects of catecholamines in the human heart. J. Cardiovasc.
Pharmacol. 19:222-232
Katzung, B.G. (2001) Basic and Clinical Pharmacology (McGraw-Hill).
Aller, S.G. et al. (2009) Structure of P-glycoprotein reveals a molecular basis for
poly-specific drug binding. Science 323:1718-1722
Dawson, R.J.P. and Locher, K.P. (2007) Structure of the multidrug ABC transporter Sav1866
from Staphylococcus aureus in complex with AMP-PNP. FEBS
Lett. 581:935-938
Bihorel, S. et al. (2007) Modulation of the brain distribution of imatinib and its
metabolites in mice by valspodar, zosuquidar and elacridar. Pharm.
Res. 24:1720-1728
Tröger, U. et al. (2005) Tetraparesis associated with colchicine is probably due to
inhibition by verapamil of the P-glycoprotein efflux pump in the blood-brain barrier. BMJ
331:613
Wada, D.R. et al. (1997) Computer simulation of the effects of alterations in blood flows
and body composition on thiopental pharmacokinetics in humans. Anesthesiology 87:884-899
Frenia, M.L. et al. (1996) Multiple-dose activated charcoal compared to urinary
alkalinization for the enhancement of phenobarbital elimination. J. Toxicol.
Clin. Toxicol. 34:169-175
Zuccato, E. et al. (2005) Cocaine in surface waters: a new evidence-based tool to monitor
community drug abuse. Environ. Health 4:14
Brunton, L.L. et al. (2005) Goodman and {Gilman}'s {The} pharmacological basis of
therapeutics (McGraw Hill).
He, K. et al. (1998) Inactivation of cytochrome P450 3A4 by bergamottin, a component of
grapefruit juice. Chem. Res. Toxicol. 11:252-259
Chrencik, J.E. et al. (2005) Structural disorder in the complex of human pregnane X
receptor and the macrolide antibiotic rifampicin. Mol.
Endocrinol. 19:1125-1134
Bauer, J. et al. (2007) A structural gap in Dpo4 supports mutagenic bypass of a major
benzo[a]pyrene dG adduct in DNA through template misalignment. Proc. Natl.
Acad. Sci. U. S. A. 104:14905-14910
McGill, M.R. and Jaeschke, H. (2013) Metabolism and disposition of acetaminophen: recent
advances in relation to hepatotoxicity and diagnosis. Pharm.
Res. 30:2174-87
Goedde, H.W. et al. (1964) Studies on pharmacogenetics. I. The enzymatic acetylation of
isonicotinic acid hydrazide (INH). Biochem.
Pharmacol. 13:1671-1675
Rashid, J.R. et al. (1992) Acetylation status using hydralazine in African hypertensives
at Kenyatta National Hospital. East Afr. Med. J. 69:406-408
Golka, K. et al. (2002) The enhanced bladder cancer susceptibility of NAT2 slow
acetylators towards aromatic amines: a review considering ethnic differences. Toxicol.
Lett. 128:229-241
Mattano, S.S. et al. (1989) Purification and biochemical characterization of hepatic
arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with
arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase. Mol.
Pharmacol. 35:599-609
Hein, P. et al. (2006) Gs activation is time-limiting in initiating receptor-mediated
signaling. J. Biol. Chem. 281:33345-33351
Gether, U. et al. (1993) Different binding epitopes on the NK1 receptor for substance P
and non-peptide antagonist. Nature 362:345-348
Hubbell, W.L. et al. (2003) Rhodopsin structure, dynamics, and activation: a perspective
from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide
cross-linking. Adv. Protein Chem. 63:243-290
Arnis, S. et al. (1994) A conserved carboxylic acid group mediates light-dependent proton
uptake and signaling by rhodopsin. J. Biol.
Chem. 269:23879-23881
Chackalamannil, S. et al. (2005) Discovery of potent orally active thrombin receptor
(protease activated receptor 1) antagonists as novel antithrombotic agents. J. Med.
Chem. 48:5884-5887
Galvez, T. et al. (2001) Allosteric interactions between GB1 and GB2 subunits are required
for optimal GABAB receptor function. EMBO J.
20:2152-2159
Ma, A.W.-.S. et al. (2007) Recovery of oligomers and cooperativity when monomers of the
M2 muscarinic cholinergic receptor are reconstituted into phospholipid
vesicles. Biochemistry 46:7907-7927
Rajeswaran, W.G. et al. (2001) Design, synthesis, and biological characterization of
bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as selective
muscarinic agonists. J. Med. Chem. 44:4563-4576
Dalpiaz, A. et al. (2012) A novel conjugated agent between dopamine and an A2A adenosine
receptor antagonist as a potential anti-Parkinson multitarget approach. Mol.
Pharm. 9:591-604
Matkovich, S.J. et al. (2006) Cardiac-specific ablation of G-protein receptor kinase 2
redefines its roles in heart development and β-adrenergic signaling. Circ.
Res. 99:996-991003
Shenoy, S.K. et al. (2006) β-Arrestin-dependent, G protein-independent ERK1/2
activation by the β2 adrenergic receptor. J. Biol.
Chem. 281:1261-1273
Piersol, G.A. (1908) Human Anatomy (Lippincott).
dos Reis, A.J. (2009) Sigmund Freud (1856-1939) and Karl Kö{}ller (1857-1944) and the
discovery of local anesthesia. Rev. Bras.
Anestesiol. 59:244-257
Zamponi, G.W. and French, R.J. (1993) Dissecting lidocaine action: diethylamide and phenol
mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle.
Biophys.
J. 65:2335-2347
Roy, M. et al. (1996) HERG, a primary human ventricular target of the nonsedating
antihistamine terfenadine. Circulation 94:817-823
Huang, L. et al. (2004) NNC 55-0396
[(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl
cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium
channels. J. Pharmacol. Exp. Ther. 309:193-199
Hannon, H.E. and Atchison, W.D. (2013) Omega-conotoxins as experimental tools and
therapeutics in pain management. Mar.
Drugs 11:680-699
Willette, R.N. et al. (2008) Systemic activation of the transient receptor potential
vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2.
J.
Pharmacol. Exp. Ther. 326:443-452
Skou, J.C. (1957) The influence of some cations on an adenosine triphosphatase from
peripheral nerves. Biochim. Biophys. Acta 23:394-401
Post, R.L. et al. (1972) Activation by adenosine triphosphate in the phosphorylation
kinetics of sodium and potassium ion transport adenosine triphosphatase. J. Biol.
Chem. 247:6530-6540
Forbush, B. (1987) Rapid release of 42K and 86Rb from an occluded state of the Na,K-pump
in the presence of ATP or ADP. J. Biol. Chem. 262:11104-11115
Chiara, D.C. et al. (2003) Identification of amino acids in the nicotinic acetylcholine
receptor agonist binding site and ion channel photolabeled by
4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist.
Biochemistry 42:271-283
Katz, B. and Thesleff, S. (1957) A study of the desensitization produced by acetylcholine
at the motor end-plate. J. Physiol. 138:63-80
Sulzer, D. et al. (2005) Mechanisms of neurotransmitter release by amphetamines: a review.
Prog.
Neurobiol. 75:406-433
Robinson, R.L. (1966) Stimulation of the release of catecholamines from isolated adrenal
glands by tyramine. J. Pharmacol. Exp. Ther. 151:55-58
Nilsson, B. et al. (2011) G protein-coupled oestrogen receptor 1 (GPER1/GPR30): a new
player in cardiovascular and metabolic oestrogenic signalling. Br. J.
Pharmacol. 163:1131-1139
Reddy, D.S. (2010) Neurosteroids: endogenous role in the human brain and therapeutic
potentials. Prog. Brain Res. 186:113-137
Vayssière, B.M. et al. (1997) Synthetic glucocorticoids that dissociate
transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol.
Endocrinol. 11:1245-1255
Janka-Junttila, M. et al. (2006) The glucocorticoid RU24858 does not distinguish between
transrepression and transactivation in primary human eosinophils. J. Inflamm.
Lond. 3:10
King, E.M. et al. (2013) Glucocorticoid repression of inflammatory gene expression shows
differential responsiveness by transactivation- and transrepression-dependent mechanisms.
PLoS
One 8:e53936
Sanz-Rodríguez, C.E. et al. (2007) Bisphosphonates as inhibitors of Trypanosoma
cruzi hexokinase: kinetic and metabolic studies. J. Biol.
Chem. 282:12377-12387
Pérez-Castrillón, J.L. et al. (2007) Effects of Atorvastatin on vitamin D
levels in patients with acute ischemic heart disease. Am. J.
Cardiol. 99:903-905
Lin, T. et al. (2018) Long-term effect of statins on the risk of new-onset osteoporosis: A
nationwide population-based cohort study. PLoS One
13:e0196713
Jaffrey, S.R. et al. (2001) Protein S-nitrosylation: a physiological signal for neuronal
nitric oxide. Nat. Cell Biol. 3:193-197
Minamiyama, Y. et al. (2007) Cytochrome P450 is responsible for nitric oxide generation
from NO-aspirin and other organic nitrates. Drug Metab.
Pharmacokinet. 22:15-19
Schrammel, A. et al. (1998) Activation of soluble guanylyl cyclase by the nitrovasodilator
3-morpholinosydnonimine involves formation of S-nitrosoglutathione. Mol.
Pharmacol. 54:207-212
Cuzzocrea, S. et al. (2002) Beneficial effects of GW274150, a novel, potent and selective
inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis. Eur. J.
Pharmacol. 453:119-129
Langenbach, R. et al. (1995) Prostaglandin synthase 1 gene disruption in mice reduces
arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell
83:483-492
Morham, S.G. et al. (1995) Prostaglandin synthase 2 gene disruption causes severe renal
pathology in the mouse. Cell 83:473-482
Rowlinson, S.W. et al. (2003) A novel mechanism of cyclooxygenase-2 inhibition involving
interactions with Ser-530 and Tyr-385. J. Biol.
Chem. 278:45763-45769
Löffler, W. et al. (1982) Influence of dietary purines on pool size, turnover, and
excretion of uric acid during balance conditions. Isotope studies using
15N-uric acid. Res. Exp. Med. Berl 181:113-123
Mehlhaff, D.L. and Stein, D.S. (1996) Gout secondary to ritonavir and didanosine. AIDS
10:1744
Choi, H.K. et al. (2004) Alcohol intake and risk of incident gout in men: a prospective
study. Lancet 363:1277-1281
Kishibe, M. et al. (2010) Chronic tophaceous gout secondary to self-induced vomiting in
anorexia nervosa. J. Dermatol. 37:578-580
Heuckenkamp, P.U. and Zöllner, N. (1971) Fructose-induced hyperuricaemia. Lancet
1:808-809
Oberhaensli, R.D. et al. (1987) Study of hereditary fructose intolerance by use of
31P magnetic resonance spectroscopy. Lancet
2:931-934
Choi, H.K. and Curhan, G. (2008) Soft drinks, fructose consumption, and the risk of gout
in men: prospective cohort study. BMJ
336:309-312
Colca, J.R. et al. (2013) Identification of a mitochondrial target of thiazolidinedione
insulin sensitizers (mTOT) –relationship to newly identified mitochondrial pyruvate
carrier proteins. PLoS One 8:e61551
Miller, R.A. et al. (2013) Biguanides suppress hepatic glucagon signalling by decreasing
production of cyclic AMP. Nature 494:256-260
Palmer, M. (2003) Efflux of cytoplasmically acting antibiotics from gram-negative
bacteria: periplasmic substrate capture by multicomponent efflux pumps inferred from their
cooperative action with single-component transporters. J.
Bacteriol. 185:5287-5289
Marquardt, J.L. et al. (1994) Kinetics, stoichiometry, and identification of the reactive
thiolate in the inactivation of UDP-GlcNAc enolpyruvoyl transferase by the antibiotic
fosfomycin. Biochemistry 33:10646-10651
Goff, D.C. (2012) D-cycloserine: an evolving role in learning and neuroplasticity in
schizophrenia. Schizophr. Bull. 38:936-941
Johnson, J.W. et al. (2010) Cyclobutanone analogues of β-lactams revisited: insights
into conformational requirements for inhibition of serine- and metallo-β-lactamases.
J. Am.
Chem. Soc. 132:2558-2560
Sulton, D. et al. (2005) Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant
S130G SHV-1 β-lactamase. Insights into the mechanism of inhibition. J. Biol.
Chem. 280:35528-35536
Xie, J. et al. (2011) A redesigned vancomycin engineered for dual D-Ala-D-ala And
D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant
bacteria. J. Am. Chem. Soc. 133:13946-13949
Zhanel, G.G. et al. (2010) New lipoglycopeptides: a comparative review of dalbavancin,
oritavancin and telavancin. Drugs 70:859-86
Palmer, A.C. and Kishony, R. (2014) Opposing effects of target overexpression reveal drug
mechanisms. Nat. Commun. 5:4296
Zhang, T. et al. (2013) Mutual inhibition through hybrid oligomer formation of daptomycin
and the semisynthetic lipopeptide antibiotic CB-182,462. Biochim.
Biophys. Acta 1828:302-308
Grein, F. et al. (2020) Ca2+-Daptomycin targets cell wall biosynthesis by
forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids.
Nat.
Commun. 11:1455
Teerlink, T. et al. (1980) The action of pimaricin, etruscomycin and amphotericin B on
liposomes with varying sterol content. Biochim.
Biophys. Acta 599:484-492
Walev, I. and Bhakdi, S. (1996) Possible reason for preferential damage to renal tubular
epithelial cells evoked by amphotericin B. Antimicrob.
Agents Chemother. 40:1116-1120
Uhlemann, A. et al. (2005) A single amino acid residue can determine the sensitivity of
SERCAs to artemisinins. Nat. Struct. Mol. Biol. 12:628-629
Cui, L. et al. (2012) Lack of association of the S769N mutation in Plasmodium
falciparum SERCA (PfATP6) with resistance to artemisinins. Antimicrob.
Agents Chemother. 56:2546-52
Luque-Ortega, J.R. and Rivas, L. (2007) Miltefosine (hexadecylphosphocholine) inhibits
cytochrome c oxidase in Leishmania donovani promastigotes. Antimicrob.
Agents Chemother. 51:1327-1332
Hoang, A.N. et al. (2010) The neutral lipid composition present in the digestive vacuole
of Plasmodium falciparum concentrates heme and mediates \gb-hematin formation with an
unusually low activation energy. Biochemistry 49:10107-10116
Gildenhuys, J. et al. (2013) The Single Crystal X-ray Structure of \gb-Hematin DMSO
Solvate Grown in the Presence of Chloroquine, a \gb-Hematin Growth-Rate Inhibitor. J. Am. Chem.
Soc. 135:1037-1047
Dwyer, J.J. et al. (2007) Design of helical, oligomeric HIV-1 fusion inhibitor peptides
with potent activity against enfuvirtide-resistant virus. Proc. Natl.
Acad. Sci. U. S. A. 104:12772-12777
Issaeva, N. et al. (2004) Small molecule RITA binds to p53, blocks p53-HDM-2 interaction
and activates p53 function in tumors. Nat. Med.
10:1321-1328
Janssen, K. et al. (2007) Apaf-1 and caspase-9 deficiency prevents apoptosis in a
Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment. Blood
110:3662-3672
Svingen, P.A. et al. (2000) Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410
on chronic myelogenous leukemia cells in vitro. Clin. Cancer
Res. 6:237-249
Ostrowski, M.L. et al. (1999) Malignant chondroblastoma presenting as a recurrent pelvic
tumor with DNA aneuploidy and p53 mutation as supportive evidence of malignancy. Skeletal
Radiol. 28:644-650
Giudici, D. et al. (1988) 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new
irreversible aromatase inhibitor. J. Steroid
Biochem. 30:391-394
Nasr, R. et al. (2008) Eradication of acute promyelocytic leukemia-initiating cells
through PML-RARA degradation. Nat. Med. 14:1333-1342
Galmarini, C.M. et al. (2002) In vivo mechanisms of resistance to cytarabine in acute
myeloid leukaemia. Br. J. Haematol. 117:860-868
Cline, S.D. and Osheroff, N. (1999) Cytosine arabinoside lesions are position-specific
topoisomerase II poisons and stimulate DNA cleavage mediated by the human type II enzymes.
J. Biol.
Chem. 274:29740-29743
Frankland-Searby, S. and Bhaumik, S.R. (2012) The 26S proteasome complex: an attractive
target for cancer therapy. Biochim. Biophys. Acta 1825:64-76
Terrano, D.T. et al. (2010) Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2
phosphorylation acts as a functional link coupling mitotic arrest and apoptosis. Mol. Cell.
Biol. 30:640-656
Fourmy, D. et al. (1996) Structure of the A site of Escherichia coli 16S ribosomal
RNA complexed with an aminoglycoside antibiotic. Science
274:1367-1371
Krebs, A. et al. (2003) Targeting the HIV trans-activation responsive
region–approaches towards RNA-binding drugs. Chembiochem 4:972-978
Welch, E.M. et al. (2007) PTC124 targets genetic disorders caused by nonsense mutations.
Nature
447:87-91
Goldmann, T. et al. (2012) A comparative evaluation of NB30, NB54 and PTC124 in
translational read-through efficacy for treatment of an USH1C nonsense mutation. EMBO Mol.
Med. 4:1186-1199
Kerem, E. et al. (2008) Effectiveness of PTC124 treatment of cystic fibrosis caused by
nonsense mutations: a prospective phase II trial. Lancet
372:719-727
Ibrahim, A.S. et al. (2003) Liposomal amphotericin B, and not amphotericin B deoxycholate,
improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob.
Agents Chemother. 47:3343-3344
Denning, D.W. and Warn, P. (1999) Dose range evaluation of liposomal nystatin and
comparisons with amphotericin B and amphotericin B lipid complex in temporarily
neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced
susceptibility to amphotericin B. Antimicrob.
Agents Chemother. 43:2592-2599
Dedon, P.C. et al. (1993) Exclusive production of bistranded DNA damage by calicheamicin.
Biochemistry 32:3617-3622
Liu, K. et al. (2010) High-throughput screening for Kv1.3 channel blockers using an
improved FLIPR-based membrane-potential assay. J. Biomol.
Screen. 15:185-195
Tanino, T. et al. (2011) Mechanistic analysis of muraymycin analogues: a guide to the
design of MraY inhibitors. J. Med. Chem. 54:8421-8439
McDaniel, R. et al. (1999) Multiple genetic modifications of the erythromycin polyketide
synthase to produce a library of novel "unnatural" natural products. Proc. Natl.
Acad. Sci. U. S. A. 96:1846-1851
Wang, D. (2008) Neurotoxins from marine dinoflagellates: a brief review. Mar.
Drugs 6:349-371
Kaplan, A.P. and Bartlett, P.A. (1991) Synthesis and evaluation of an inhibitor of
carboxypeptidase A with a Ki value in the femtomolar range. Biochemistry 30:8165-8170
Trott, O. and Olson, A.J. (2010) AutoDock Vina: improving the speed and accuracy of
docking with a new scoring function, efficient optimization, and multithreading. J. Comput.
Chem. 31:455-461
Sufrin, J.R. et al. (1981) Steric mapping of the L-methionine binding site of
ATP:L-methionine S-adenosyltransferase. Mol.
Pharmacol. 19:307-313
Rubin, R.P. (2007) A brief history of great discoveries in pharmacology: in celebration of
the centennial anniversary of the founding of the American Society of Pharmacology and
Experimental Therapeutics. Pharmacol. Rev. 59:289-359